Nichols: Lung Cancers Flashcards
In general, lung cancers are more common and fatal in what sex/race? less common less fatal?
black males > asians and hispanics
3 major types of lung cancer
adenocarcinoma
squamous cell
small cell
assc with inapproprate ADH expression
small cell
–> leads to hyponatremia
more commonly peripherial
adenocarinomas
assc with Easton-Lambert syndrome
small cell
*due to autoantibodies against P/Q type voltage-gated calcium channels
commonly causes hypercalcemia
squamous cell carcinomas
**due to the production of a substance resembling parathyroid hormone
commonly metastatic at presentation
small cell
causes post-obstructive pneumonia
squamous cell carcinoma
more commonly central
small cell
commonly causes cavitation
squamous cell
assc with cushing syndrome
small cell
more common in women, asians, and never smokers
adenocarcinomas
common symptoms assc with lung cancer
cough (60%) > dyspnea > weight loss, hemoptysis > chest pain > horeseness (10%)
common signs assc with lung cancer
none
How is lung cancer Dx?
- discover via radiology (screen 55-80 y/o with 30+ pack-years Hx)
- biopsy
What type of lung cancer is tx with sugery
early stage squamous and adenocarcinoma (aka non-small cell)
treatment for non-small cell carcinoma
early stages: surgery
later stages: chemo (carboplatin + docataxel)
drug target for mutated ALK
crizotinib
WHat is the prognosis of lung caner as a whole?
5 year survival of 17%
malignant epithelial tumor of lung with glandular features such as making glands or mucin
adenocarcinoma (lung primary adenocarcinoma)
70% of never smokers with lung cancer have
adenocarcinoma
role of filtered cigarettes in the increased of adenocarcinoma
filter removed large particles = increased particle deposition in small airways
other causes of adenocarcinoma other than cigarette smoke
radon gas from ground
radiation
asbestos
Mutation common in adenocarcinomas of never smokers
EGFR
Mutation common in adenocarcinomas of smokers
KRAS
KRAS mutation confers resistance to what drug?
erlotinib
EGFR mutations confers responsiveness to what drug?
gefitinib and erlotinib
crizotinib effectiveness requires what mutation?
EML4-ALK translocation fusion oncogene
*it is an ALK inhibitor
What mutations are seen in adenocarcinoms?
EFGR KRAS EML4-ALK p53 c-MET NKX2-1 PIK3CA BRAF
Tx for inoperable adenocarcinomas
pemetrexed
antifolate metabolite inhibitor of thymidylate synthetase, inhibiting the formation of precursor purine and pyrimidine nucleotides, preventing the formation of DNA and RNA
pemetrexed
anti-vascular endothelial growth factor (VEGF) monoclonal antibody
bevacizumab
What microscopic pathologies of adenocarcinoma are assc with a good prognosis?
bad?
good: lepidic (without invasion) = spreading within alveoli
bad: micopapillary, solid
Tx options for adenocarcinomas
erlotinib, pemetrexed, bevacizumab
prognosis for adenocarcinomas
determined by stage:
early stage live about 20 months on average
late stage about 13 months
**no KRAS = + 5 mos
**EML4-ALK translocation fusion oncogene + 5 mos
Describe the common pathology of adenocarcinomas
peripheral, subpleural, solitary, lobulated or spiculated
non-invasive neoplasm characterized by non-destructive growth along intact alveolar septa
adenocarcinoma in situ
involves type II pneumocytes and Clara cells
non-mucinous adenocarcinoma in situ
metaplasia of bronchilar epithelium
municnous adenocarcinoma in situ
can become mulitfocal from tumor spread via airways and the mucocilliary escalator
municnous adenocarcinoma in situ
CK20 negative and TTF-1 positive
non-mucinous adenocarcinoma in situ
KRAS + and EGFR –
municnous adenocarcinoma in situ
CK20 postitive and TTF-1 negative
municnous adenocarcinoma in situ
KRAS – and EGFR +
non-mucinous adenocarcinoma in situ
size difference between lesions of adenocarcinoma in situ and lung primary adenocarcinoma
in situ: < 2 cm
primary: > 4 cm
Tx for adenocarcinoma in situ
Surgical resection
Inoperable:
- erlotinib for EGFR +
- crizotinib for ALK+
- paclitaxel for EGFR – (mitotic inhibitor)
mucinous or non-mucinous adenocarcinoma in situ has a better prognosis
non-mucinous
desmoplastic reaction
lung primary adenocarcinoma
- occurs around glandular structures
- *makes it very firm to palpation
anthroacotic pigment
lung primary adenocarcinoma
lepidic growth
adenocarcinoma in situ
= non destructive growth long intact alveolar septa
large endobronchial mass
squamous cell carcinoma
Where do squamous cell carcinomas typically arise
2/3 from main, lobar, or segmental
1/3 from small periph bronchi
What tx is contraindicated in squamous cell carcinoma
bevacizumab bc it was assc with hemorrhaging
Optimal Tx for squamous cell carcinoma
surgical resection
radiation is suboptimal
Tx for small cell carcinoma
cisplatin or carboplatin + etopside + radiation
topoisomerase inhibitor that forms a complex with DNA and the enzyme, preventing re-ligation of DNA strands, causing them to break
etopside
are primary lung tumors or pulmonary mets more common
Why?
pulm mets
- receive entire RT heart blood flow with every heart beat
- densest capillary bed in body
- 1st capillary bed met by venous return from every other organ
- 1st capillary bed met by lymphatic drainage after being dumped into SVC by thoracic duct
- lots of O2!
WHat are the primary sites of lung mets?
Breast Colon Stomach Melanoma Prostate Liver Thyroid
Little Boys Prefer To Meet Silly Cunts
______ tend to metastasize to lungs because they tend to spread by vein (hematogenously) rather than by lymphatic channels (characteristic of ________)
sarcomas
carcinomas
Lymphangitic carcinomatosis
metastatic disease can fill lymphatics and infiltrate interstitium without creating mass lesions
CK7 and TTF-1 positive and CK20 and CDX2 negative
lung primary tumor
CK20 and CDX2 positive and CK7 and TTF-1 negative
colon primary
CK7 positive and CK20, CDX2 and TTF-1 negative
breast primary
How do lung mets appear compared than primaries
Smaller and rounder
Lung mets usually appear in what area of the lung
Lower/base
The bigger lung mets are usually in what area of the lung
Lower/base
acinar type
Lung primary adenocarcinoma
Intracellular bridges
Squamous cell carcinoma
Invades submucosal space
Small cell
Most likelt to cause hemoptysis
Squamous cell carcinoma
Keratin pearls
Squamous cell carcinoma
replacing alveolar lining
Adenocarcinoma in situ
Near 100% of cell in this type are p63 positive
Squamous cell carcinoma
Facial, cervical, and arm edema
Small cell
Usually metastaic and responsive to chemo
Small cell
100% of cells in this type are p40 positive
Squamous cell carcinoma
“salt and peper” nuclear chromatin
Small cell
Many mitoses
Small cell
Extensive necrosis
Small cell
Assc with bronchiectasis
Squamous cell carcinoma
Male smoker
Small cell > Squamous cell > adenocarcinoma
Female smoker
Adenocarcinoma
keratinization
Squamous cell carcinoma
Telomerae mutation
Small cell
RASSF mutations
Small cell
RB1 mutation
Small cell
Parabronchial (without an endobronchial mass)
Small cell
Central, endobronchial, cavitiating, hemoptysis
Squamous cell carcinoma
Large central tumor + extensive metastases
Small cell
**usually to nearby LN first
peripheral, subpleural, solitary, lobulated or speculated lung lesion
adenocarcinoma
Causes atelectasis
Squamous cell carcinoma
pancytokeratin positive
Small cell
Bcl-2 assc with
Small cell
FHIT assc with
small cell
Most likely to cause a paraneoplastic syndrome
Small cell
Spiculation
Squamous cell carcinoma
= central hemorrhage
Pemberton’s sign
Small cell
= development of facial flushing
Most aggressive type of lung cancer
Small cell
Most responsive to chemo
Small cell
Neuroendocrine carcinoma
Small cell
pneumonia-like area of consolidation
Adenocarcinoma in situ
Smooth pick eosinophillic cytoplasm
Squamous cell carcinoma
SVC syndrome
Small cell
Inspiratory stridor when pts raise both arm above head
Small cell